Previous 10 | Next 10 |
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at Oppenheimer’s 33 rd Annual Healthcare Conference taking place virtually from March 13-...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates’ 44 th Annual Institutional Investors Conference, s...
Data sharing partnership will expand chemical coverage space and improve model performance in support of new approach methodologies to ensure product safety Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical...
NAFLDsym v2B Beta represents the first release in the faster, sleeker Julia infrastructure Simulations Plus, Inc . (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of NAFL...
Summary Simulations Plus has been beaten down over the FY22' period to date, but has curled up off lows into the new year. It is a niche operator presenting with a differentiated offering for those speculating on clinical-stage assets. Shares are richly priced but this can be justif...
DSX is faster, more user-friendly, and scalable for high-performance computing Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) div...
Simulations Plus ( NASDAQ: SLP ) has entered into an accelerated share repurchase agreement with Morgan Stanley & Co to repurchase an aggregate of $20M of shares. The ASR agreement is part of the $50M share repurchase program authorized by the Board of Directors on Decem...
Initiates first steps in updated capital allocation strategy Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced it has entered into an accelerated share repurchase agreement (t...
Simulations Plus, Inc. (SLP) Q1 2023 Results Conference Call January 04, 2023 05:00 PM ET Company Participants Brian Siegel - Hayden IR Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Officer Conference Call Participants Matt Hewit...
Simulations Plus press release ( NASDAQ: SLP ): Q1 GAAP EPS of $0.06 misses by $0.03 . Revenue of $11.96M (-3.7% Y/Y) misses by $0.47M . Software revenue decreased 17% to $6.1 million, representing 51% of total revenue; Services revenue increased 17% to $5.9 millio...
News, Short Squeeze, Breakout and More Instantly...
Objective to define best practices for the use of novel PBK modeling strategies to support animal-free safety assessment of new chemicals Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance an...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...